Marc Bifano

1.7k total citations
42 papers, 1.3k citations indexed

About

Marc Bifano is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Marc Bifano has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hepatology, 23 papers in Epidemiology and 15 papers in Infectious Diseases. Recurrent topics in Marc Bifano's work include Hepatitis C virus research (25 papers), HIV/AIDS drug development and treatment (15 papers) and Hepatitis B Virus Studies (11 papers). Marc Bifano is often cited by papers focused on Hepatitis C virus research (25 papers), HIV/AIDS drug development and treatment (15 papers) and Hepatitis B Virus Studies (11 papers). Marc Bifano collaborates with scholars based in United States, Germany and Japan. Marc Bifano's co-authors include Robert Hamatake, Daniel J. Tenney, Warren Hurlburt, Dennis M. Grasela, Hamza Kandoussi, Richard Bertz, Eric Hughes, Dessislava I. Dimitrova, R. Hindes and Robert J. Fontana and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Chemistry and Hepatology.

In The Last Decade

Marc Bifano

41 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Bifano United States	22	859	823	378	164	139	42	1.3k
Eisuke Murakami Japan	25	1.1k 1.2×	1.3k 1.6×	658 1.7×	459 2.8×	188 1.4×	102	2.1k
Preethi Krishnan United States	26	1.2k 1.4×	1.5k 1.8×	734 1.9×	407 2.5×	81 0.6×	58	2.1k
Marc P. Windisch South Korea	21	574 0.7×	565 0.7×	410 1.1×	502 3.1×	95 0.7×	57	1.6k
Véronique Descamps France	20	761 0.9×	916 1.1×	181 0.5×	254 1.5×	118 0.8×	35	1.5k
Kai Lin United States	25	919 1.1×	1.0k 1.2×	588 1.6×	579 3.5×	216 1.6×	50	2.0k
Christine Espiritu United States	17	1.0k 1.2×	1.1k 1.4×	810 2.1×	502 3.1×	77 0.6×	34	1.8k
Congrong Niu United States	18	1.2k 1.4×	1.1k 1.4×	842 2.2×	674 4.1×	157 1.1×	29	2.1k
Cynthia A. Gates United States	17	407 0.5×	437 0.5×	343 0.9×	295 1.8×	45 0.3×	31	1.2k
Isabelle Cannie France	12	1.1k 1.3×	991 1.2×	180 0.5×	470 2.9×	238 1.7×	17	1.9k
Joseph M. Colacino United States	24	794 0.9×	340 0.4×	618 1.6×	730 4.5×	116 0.8×	67	2.0k

Countries citing papers authored by Marc Bifano

Since Specialization

Citations

This map shows the geographic impact of Marc Bifano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Bifano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Bifano more than expected).

Fields of papers citing papers by Marc Bifano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Bifano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Bifano. The network helps show where Marc Bifano may publish in the future.

Co-authorship network of co-authors of Marc Bifano

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Bifano. A scholar is included among the top collaborators of Marc Bifano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Bifano. Marc Bifano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prichett, Laura, et al.. (2025). Suicide Risk Screening in a Diverse Cohort of Youth With Type 1 and Type 2 Diabetes. Pediatric Diabetes. 2025(1). 6662248–6662248.

Zhu, Li, Hanbin Li, Phyllis Chan, et al.. (2018). Population Pharmacokinetic Analysis of Asunaprevir in Subjects with Hepatitis C Virus Infection. Infectious Diseases and Therapy. 7(2). 261–275. 4 indexed citations

Chan, Phyllis, Hanbin Li, Li Zhu, et al.. (2017). Population Pharmacokinetic Analysis of Daclatasvir in Subjects with Chronic Hepatitis C Virus Infection. Clinical Pharmacokinetics. 56(10). 1173–1183. 11 indexed citations

Chan, Phyllis, et al.. (2016). Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations. Clinical Pharmacokinetics. 55(12). 1559–1572. 2 indexed citations

Garimella, Τushar, Xiaoli You, Shu‐Pang Huang, et al.. (2016). A Review of Daclatasvir Drug–Drug Interactions. Advances in Therapy. 33(11). 1867–1884. 21 indexed citations

Eley, Timothy, Shu‐Pang Huang, Bing He, et al.. (2014). The Pharmacokinetics of Daclatasvir and Asunaprevir Administered in Combination in Studies in Healthy Subjects and Patients Infected with Hepatitis C Virus. Clinical Drug Investigation. 34(9). 661–671. 17 indexed citations

Garimella, Τushar, Wen‐Lin Luo, Philip Wastall, et al.. (2014). Evaluation of drug‐drug interaction between daclatasvir and methadone or buprenorphine/naloxone. Journal of the International AIDS Society. 17(4S3). 19628–19628. 5 indexed citations

Fontana, Robert J., Eric Hughes, Marc Bifano, et al.. (2013). Sofosbuvir and Daclatasvir Combination Therapy in a Liver Transplant Recipient With Severe Recurrent Cholestatic Hepatitis C. American Journal of Transplantation. 13(6). 1601–1605. 112 indexed citations

Jiang, Hao, Jianing Zeng, Wenying Li, et al.. (2012). Practical and Efficient Strategy for Evaluating Oral Absolute Bioavailability with an Intravenous Microdose of a Stable Isotopically-Labeled Drug Using a Selected Reaction Monitoring Mass Spectrometry Assay. Analytical Chemistry. 84(22). 10031–10037. 34 indexed citations

10.

Fontana, Robert J., Eric Hughes, Henry D. Appelman, et al.. (2012). Case report of successful peginterferon, ribavirin, and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation. Liver Transplantation. 18(9). 1053–1059. 51 indexed citations

11.

Jiang, Hao, Jianing Zeng, Hamza Kandoussi, et al.. (2012). A sensitive and accurate liquid chromatography–tandem mass spectrometry method for quantitative determination of the novel hepatitis C NS5A inhibitor BMS-790052 (daclastasvir) in human plasma and urine. Journal of Chromatography A. 1245. 117–121. 33 indexed citations

12.

Gu, Huidong, Jian Wang, Anne‐Françoise Aubry, et al.. (2012). Calculation and Mitigation of Isotopic Interferences in Liquid Chromatography–Mass Spectrometry/Mass Spectrometry Assays and Its Application in Supporting Microdose Absolute Bioavailability Studies. Analytical Chemistry. 84(11). 4844–4850. 32 indexed citations

13.

Fridell, Robert A., Chunfu Wang, Jin-Hua Sun, et al.. (2010). Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations. Hepatology. 54(6). 1924–1935. 186 indexed citations

14.

Bifano, Marc, et al.. (2007). Absence of a Pharmacokinetic Interaction Between Entecavir and Adefovir. The Journal of Clinical Pharmacology. 47(10). 1327–1334. 10 indexed citations

15.

Bifano, Marc, Steven Olsen, Robert A. Smith, et al.. (2006). Entecavir Pharmacokinetics, Safety, and Tolerability After Multiple Ascending Doses in Healthy Subjects. The Journal of Clinical Pharmacology. 46(11). 1250–1258. 50 indexed citations

16.

Hamatake, Robert, Marc Bifano, Warren Hurlburt, & Daniel J. Tenney. (1997). A functional interaction of ICP8, the herpes simplex virus single-stranded DNA-binding protein, and the helicase-primase complex that is dependent on the presence of the UL8 subunit.. Journal of General Virology. 78(4). 857–865. 34 indexed citations

17.

Tenney, Daniel J., Amy K. Sheaffer, Warren Hurlburt, Marc Bifano, & Robert Hamatake. (1995). Sequence-dependent Primer Synthesis by the Herpes Simplex Virus Helicase-Primase Complex. Journal of Biological Chemistry. 270(16). 9129–9136. 23 indexed citations

18.

Sheaffer, Amy K., Warren Hurlburt, John T. Stevens, et al.. (1995). Characterization of monoclonal antibodies recognizing amino- and carboxy-terminal epitopes of the herpes simplex virus UL42 protein. Virus Research. 38(2-3). 305–314. 7 indexed citations

19.

Tenney, Daniel J., John T. Stevens, Robert Hamatake, et al.. (1993). Mutations in the C terminus of herpes simplex virus type 1 DNA polymerase can affect binding and stimulation by its accessory protein UL42 without affecting basal polymerase activity. Journal of Virology. 67(1). 543–547. 36 indexed citations

20.

Hamatake, Robert, Marc Bifano, Daniel J. Tenney, Warren Hurlburt, & Michael G. Cordingley. (1993). The herpes simplex virus type 1 DNA polymerase accessory protein, UL42, contains a functional protease-resistant domain. Journal of General Virology. 74(10). 2181–2189. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact